MOLLY ELLIOTT: Open Payments
NPI 1407190291 · VESTAVIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,820 in 111 payments from 18 companies in 2025. Trend: 2023 $1,507 · 2024 $1,685 · 2025 $1,820
Food & beverage: $1,820
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $413 |
| Novo Nordisk Inc | 20 | $328 |
| PFIZER INC. | 14 | $287 |
| Axsome Therapeutics, Inc. | 10 | $246 |
| Lilly USA, LLC | 5 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| SHIELD THERAPEUTICS INC | 3 | $60 |
| Amgen Inc. | 3 | $59 |
| Lundbeck LLC | 2 | $37 |
Products named: Symbravo, NURTEC ODT, VRAYLAR, Wegovy, QULIPTA, UBRELVY, ELIQUIS, Ozempic.
Industry payments across AL — which companies pay providers there.
